Internal Medicine, Nephrology · Tupelo, MS
NPI
1508245226
Since 2015
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1542 Medical Park Cir
Tupelo, MS, 38801
Phone (662) 844-4711
Groups this clinician bills Medicare through
Medicare paid, 2024
$249K
4,868 services
Medicare patients, 2024
687
Average age 72
Drug cost, 2024
$988K
1,618 prescriptions
Company payments, 2025
$923
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John W Elliott was code 36415 (venipuncture blood collection), 524 times for 371 patients. In total John W Elliott billed 4,868 services in 28 codes, and Medicare paid $249K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 524 | 371 | $8.62 | $4,517 |
| 85025 Blood Count | Office | 501 | 368 | $7.59 | $3,803 |
| 81002 Clinical Chemistry | Office | 492 | 361 | $3.40 | $1,674 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 485 | 352 | $11.76 | $5,703 |
| 84100 Clinical Chemistry | Office | 473 | 339 | $4.64 | $2,194 |
| 80053 Clinical Chemistry | Office | 469 | 337 | $10.32 | $4,841 |
| 90960 ESRD Related Services (not dialysis) | Office | 414 | 71 | $257.27 | $107K |
| 99214 Office E&M - Established | Office | 404 | 322 | $53.65 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 211 | 99 | $85.52 | $18K |
| 90935 Hemodialysis | Facility | 152 | 89 | $51.70 | $7,858 |
| 99232 Hospital E&M - Subsequent | Facility | 110 | 76 | $57.46 | $6,321 |
| 99215 Office E&M - Established | Office | 109 | 80 | $83.37 | $9,087 |
| 99223 Hospital E&M - Initial | Facility | 92 | 87 | $124.19 | $11K |
| 99222 Hospital E&M - Initial | Facility | 63 | 56 | $92.79 | $5,846 |
| 90961 ESRD Related Services (not dialysis) | Office | 57 | 40 | $209.87 | $12K |
By year: 2022 $291K for 5,291 services; 2023 $231K for 4,247 services; 2024 $249K for 4,868 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 524 | 371 | $8.62 | $4,517 |
| 85025 Blood Count | 501 | 368 | $7.59 | $3,803 |
| 81002 Clinical Chemistry | 492 | 361 | $3.40 | $1,674 |
| 84100 Clinical Chemistry | 473 | 339 | $4.64 | $2,194 |
| 80053 Clinical Chemistry | 469 | 337 | $10.32 | $4,841 |
| 80069 Clinical Chemistry | 43 | 41 | $8.51 | $366 |
| 82306 Clinical Chemistry | 27 | 26 | $29.01 | $783 |
Medicare prescription drug claims, 2024
In 2024, the drug John W Elliott prescribed most often to Medicare patients was Sevelamer Carbonate, with 159 prescriptions and refills. In total John W Elliott wrote 1,618 Medicare prescriptions that cost $988K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 159 | 340 | 57 | $40K |
| Velphoro Sucroferric Oxyhydroxide | 142 | 202 | 39 | $518K |
| Torsemide Generic | 123 | 262 | 49 | $1,371 |
| Amlodipine Besylate Generic | 97 | 210 | 36 | $468 |
| Losartan Potassium Generic | 94 | 217 | 32 | $781 |
| Chlorthalidone Generic | 66 | 171 | 28 | $1,195 |
| Allopurinol Generic | 63 | 115 | 22 | $618 |
| Farxiga Dapagliflozin Propanediol | 59 | 81 | 18 | $45K |
| Spironolactone Generic | 54 | 119 | 25 | $358 |
| Lisinopril Generic | 53 | 113 | 16 | $307 |
| Carvedilol Generic | 52 | 116 | 19 | $247 |
| Jardiance Empagliflozin | 35 | 66 | 12 | $37K |
| Pantoprazole Sodium Generic | 33 | 51 | Under 11 | $290 |
| Lanthanum Carbonate Generic | 30 | 40 | Under 11 | $36K |
| Hydrochlorothiazide Generic | 26 | 54 | Under 11 | $60.6 |
Brand drugs: 333 claims; generic drugs: 1,285 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John W Elliott $923 ($923 in general payments such as food, travel and fees) from 15 companies. The largest payer was Fresenius USA Marketing, Inc. with $272.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 15 | $272 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $95.4 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $71.3 |
| Novo Nordisk Inc NVO | 4 | $60.58 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $60.16 |
| Mallinckrodt Hospital Products Inc. | 2 | $43.11 |
| OPKO Pharmaceuticals, LLC | 2 | $42.89 |
| Travere Therapeutics, Inc. TVTX | 1 | $37.2 |
| Calliditas Therapeutics US Inc. | 1 | $21.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.